Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: An evaluation using the AGREE instrument

BMC Medicine

Volumn 10, Issue , 2012, Pages 1-9

  Simone, Benedetto ^a   De Feo, Emma ^a   Nicolotti, Nicola ^a   Ricciardi, Walter ^a   Boccia, Stefania ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

BRCA1 2; Breast cancer; Cancer screening; Cancer surveillance; Familial breast ovarian cancer

Indexed keywords

APPRAISAL OF GUIDELINES, RESEARCH AND EVALUATION INSTRUMENT; ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL ASSESSMENT TOOL; CONFLICT OF INTEREST; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HIGH RISK PATIENT; HUMAN; MEDICAL SOCIETY; METHODOLOGY; PRACTICE GUIDELINE; RISK ASSESSMENT; FEMALE; HEALTH SERVICES RESEARCH; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; QUALITY CONTROL; STANDARD;

FEMALE; GENETIC TESTING; GUIDELINES AS TOPIC; HEALTH SERVICES RESEARCH; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMANS; QUALITY CONTROL;

EID: 84890230595     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-143     Document Type: Article

References (29)

1. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011, 19(1):CD001877.
2. National Cancer Comprehensive Network (NCCN) Breast Cancer Screening and Diagnosis. National Cancer Comprehensive Network (NCCN)., http://demystifyingmedicine.od.nih.gov/DM10/0413-BreastCancer/NCCN%20bre ast-screening.pdf
3. Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK. Hereditary breast and ovarian cancer new genes, new treatments, new concepts. Dtsch Arztebl Int 2011, 108(19):323-330. 3106175, 21637635.
4. The AGREE Collaboration Appraisal of Guidelines for Research & Evaluation (AGREE) instrument. The AGREE Collaboration., http://www.agreecollaboration.org
5. Shinohara Y, Nagayama M, Origasa H. Postpublication external review of the Japanese guidelines for the management of stroke 2004. Stroke 2009, 40:1439-43. 10.1161/STROKEAHA.108.535070, 19228839.
6. Qaseem A, Snow V, Shekelle P, Hopkins R, Owens DK. Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med 2009, 150:125-31.
7. Sinuff T, Patel RV, Adhikari NK, O Meade M, Schunemann HJ, Cook DJ. Quality of professional society guidelines and consensus conference statements in critical care. Crit Care Med 2008, 36:1049-58. 10.1097/CCM.0b013e31816a01ec, 18379228.
8. Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P,. for the International Consensus Upper Gastrointestinal Bleeding Conference Group International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010, 152:101-13. for the International Consensus Upper Gastrointestinal Bleeding Conference Group.
9. Simons MP, Aufenacker T, Bay-Nielsen M, Bouillot JL, Campanelli G, Conze J, de Lange D, Fortelny R, Heikkinen T, Kingsnorth A, Kukleta J, Morales-Conde S, Nordin P, Schumpelick V, Smedberg S, Smietanski M, Weber G, Miserez M. European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia 2009, 13:343-403. 10.1007/s10029-009-0529-7, 2719730, 19636493.
10. Burgers JS, Fervers B, Haugh M, Brouwers M, Browman G, Philip T, Cluzeau FA. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation instrument. J Clin Oncol 2004, 22:2000-7. 10.1200/JCO.2004.06.157, 15143093.
11. Simone B, De Feo E, Nicolotti N, Ricciardi W, Boccia S. Quality evaluation of guidelines on genetic screening, surveillance and management of hereditary colorectal cancer. Eur J Public Health 2011
12. Gorman SK, Chung MH, Slavik RS, Zed PJ, Wilbur K, Dhingra VK. A critical appraisal of the quality of 55 critical care pharmacotherapy clinical practice guidelines and their strength of recommendations. Intensive Care Med 2010, 36(10):1636-43. 10.1007/s00134-010-1786-8, 20217048.
13. van Diermen DE, Aartman IH, Baart JA, Hoogstraten J, van der Waal I. Dental management of patients using antithrombotic drugs: critical appraisal of existing guidelines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:616-24. 10.1016/j.tripleo.2009.01.038, 19426918.
14. Barajas-Nava L, Solà I, Delgado-Noguera M, Gich I, Villagran CO, Bonfill X, Alonso-Coello P. Quality assessment of clinical practice guidelines in perioperative care: a systematic appraisal. Qual Saf Health Care 2010, 19:e50.
15. Lee HP, Chew CT, Consigliere DT, Heng D, Huang DT, Khoo J, Khoo KS, Low J, Lui S, Ooi LL, Puvanendran R, Siow A, Tan A, Yeoh KG. Ministry of health clinical practice guidelines: cancer screening. Singapore Med J 2010, 51(2):170-3. quiz 174-5.
16. ACOG Committee on Practice Bulletins Hereditary breast and ovarian cancer syndrome. Gynecol Oncol. 2009, 113(1):6-11. ACOG Committee on Practice Bulletins.
17. Institute for Clinical Systems Improvement Health care guideline: evaluation by primary care of patient with symptoms of potential breast disease. Institute for Clinical Systems Improvement., http://www.icsi.org/breast_disease/diagnosis_of_breast_disease_for_patie nts_families_.html
18. New Zealand Guidelines Group Management of early breast cancer. New Zealand Guidelines Group., http://www.nzgg.org.nz/library_resources/5_breast_cancer_guideline
19. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA,. for the American Cancer Society Breast Cancer Advisory Group American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89. 10.3322/canjclin.57.2.75, 17392385, for the American Cancer Society Breast Cancer Advisory Group.
20. Berliner JL, Fay AM,. Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest Group Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 2007, 16(3):241-60. 10.1007/s10897-007-9090-7, 17508274, Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest Group.
21. University of Michigan Health System Guidelines for clinical care. Adult preventive health care: cancer screening. University of Michigan Health System., http://www.med.umich.edu/1info/fhp/practiceguides/adult.cancer/cancergli ne.pdf
22. Toward Optimized Practice, Alberta Medical Association Guideline for the early detection of breast cancer. Toward Optimized Practice, Alberta Medical Association., http://www.topalbertadoctors.org/cpgs.php?sid = 2&cpg_cats = 12
23. National Institute for Health and Clinical Excellence Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. National Institute for Health and Clinical Excellence., http://www.nice.org.uk/nicemedia/pdf/CG41NICEguidance.pdf
24. National Institute for Health and Clinical Excellence Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Update of Clinical Guideline. National Institute for Health and Clinical Excellence., http://www.nice.org.uk/nicemedia/live/10994/30247/30247.pdf
25. U.S. Preventive Services Task Force Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005, 6;143(5):355-61. U.S. Preventive Services Task Force.
26. Scottish Intercollegiate Guidelines Network (SIGN) Management of breast cancer in women: a national clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN)., http://www.sign.ac.uk/pdf/sign84.pdf
27. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003, 53(3):141-69. 10.3322/canjclin.53.3.141, 12809408.
28. Parmigiani G, Berry DA, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998, 62:145-158. 10.1086/301670, 1376797, 9443863.
29. Antoniou A, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah PD. Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 2008, 45(7):425-31. 10.1136/jmg.2007.056556, 18413374.